Notably, ACSL4 (acyl-CoA synthetase long-chain family member 4) has emerged as a significant player, as its high expression has been linked to promoting prostate cancer growth, invasion, and hormonal resistance, thereby contributing to disease aggressiveness (Wu et al., 2015). The gene discussed is ACSL4; the disease is prostate cancer.